![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacology, the Chinese University of Hong Kong, Hong Kong, SAR (G.L., J.T., X.Q.L., Y.J.); and Center for Developmental Pharmacology and Toxicology, Seattle Children's Hospital Research Institute, Division of Gastroenterology, Department of Pediatrics, University of Washington, Seattle, Washington (J.Z.)
(Received November 28, 2006; Accepted January 17, 2007)
| Abstract |
|---|
|
|
|---|
21%), the metabolic activation in female rats was significantly lower (
4%) possibly because of significantly lower CYP3A1/2 levels expressed in female rats. Second, a direct hydrolysis to generate the novel female rat-specific metabolite deacetylclivorine was shown as the predominant pathway (
16% clivorine metabolism) in female rat liver microsomes and was determined to be mediated by microsomal hydrolase A. Furthermore, when the metabolic activation was completely inhibited by ketoconazole, the amount of deacetylclivorine formed in a 1-h incubation significantly increased from 19.44 ± 3.00 to 54.87 ± 9.30 nmol/mg protein, suggesting that the two pathways compete with each other. Therefore, the lower susceptibility of female SD rats to clivorine intoxication is suggested to be caused by the significantly higher extent of the direct hydrolysis and a lower degree of the metabolic activation.
|
| Materials and Methods |
|---|
|
|
|---|
99%), respectively. Instrumentation. The on-line HPLC-UV/MS analyses for the identification of metabolites generated from microsomal incubations were performed on an Agilent Technologies (Palo Alto, CA) 1100 Liquid Chromatograph system connected to a photodiode-array multiple-wavelength UV detector and a Thermo Electron Corporation (Waltham, MA) TSQ 7000 mass spectrometer coupled with an electrospray ionization interface. Both positive and negative ion mode of MS and MS/MS analyses were carried out on the same HPLC/MS setup with direct loop infusions. Another Agilent 1100 system coupled with a photodiode-array multiple-wavelength UV detector was used for all the HPLC-UV quantitative analyses.
Animals and Preparation of Liver Microsomes. Adult female SD rats (body weight 220250 g) were supplied by the Laboratory Animal Services Centre at the Chinese University of Hong Kong. Female rat liver microsomes and cytosolic fractions were prepared by a standard procedure (Lin et al., 2000a
, 2002
, 2003
). Protein content was determined using the modified method of Lowry et al. (1951
). P450 content was determined by a standard procedure (Omura and Sato, 1964
; Lin et al., 2000a
, 2003
). The prepared subcellular fractions were stored in portions at 80°C until used.
Microsomal Incubation and Treatment of Incubated Samples. Our previous reported procedure (Lin et al., 2000a
, 2002
, 2003
) was adopted for the present study. Briefly, a typical 1-ml microsomal or cytosolic incubation mixture consisted of potassium phosphate buffer (0.1 M, pH 7.4) containing liver microsomes or cytosolic incubation (2 mg protein/ml), 250 µM clivorine, and 2.0 mM GSH with or without the NADPH-generating system (5 mM MgCl2, 1 mM ß-NADP+, 10 mM glucose 6-phosphate, and 1 unit/ml of glucose-6-phosphate dehydrogenase). The reaction was initiated by adding the substrate (clivorine), proceeded at 37°C for 60 min, and then terminated by chilling in an ice bath. A consistent concentration of clivorine at 250 µM was selected in all the incubations and the enzyme inhibition studies described below. This concentration was comparable with those tested in our previous in vitro study of rat liver microsomal metabolism of clivorine to form DHR-derived DNA adducts, leading to hepatotoxicity (Xia et al., 2004
). In addition, the same concentration was also tested in male rat live microsomal metabolism of clivorine (Lin et al., 2000a
, 2003
); thus, the present results can be directly compared with those obtained previously from male rat studies. The incubation time was chosen for 1 h based on our previously established methods (Lin et al., 2000a
, 2002
, 2003
) and also the results of the initial test on the different incubation times in the present study. The formation rates of all the metabolites identified were linear within 45 to 60 min; all reached the peak at 60 min, and then remained in plateau for at least 2 h (data not shown). Furthermore, incubations with female rat liver S9 and male rat liver S9, microsomal and cytosolic fractions for the comparison and various controls, including using phosphate buffer or denatured microsomes, and incubation in the absence of substrate were conducted in parallel. Incubation under each individual condition was conducted at least in triplicate. The resultant ice-cold incubates were immediately centrifuged at 105,000g at 2°C for 20 min. Aliquots (200 µl) of the supernatant were filtered and subjected to HPLC systems for qualitative and quantitative analyses.
Enzyme Inhibition Studies. Four selective P450 inhibitors [10 µM pilocarpine to CYP2A1 (Kimonen et al., 1995
; Lewis, 1998
); 30 µM diethyldithiocarbamate to CYP2E1 (Eagling et al., 1998
); 5 µM ketoconazole to CYP3A1/2 (Ghosal et al., 1996
; Shayeganpour et al., 2006
); and 100 µM sulfaphenazole to CYP2C subfamily (Eagling et al., 1998
)] and two carboxylesterase inhibitors (TOCP, a nonselective microsomal carboxylesterase inhibitor, and PMSF, a selective hydrolase A inhibitor) at various concentrations were used to study their effects on the microsomal metabolism of clivorine in female rats. The concentrations of individual P450 inhibitors utilized were chosen based on the published reports as indicated above, to achieve significant inhibitions of the corresponding isozymes in rat liver microsomes. In the case of inhibition of the tested P450 isozymes, 10-min preincubation with individual inhibitors in the presence of the NADPH-generating system was conducted, followed by incubations under the aforementioned condition except for the absence of GSH. Furthermore, controls in the absence of inhibitors were treated identically for direct comparison. For the inhibition of carboxylesterase, both TOCP and PMSF were dissolved in dimethyl sulfoxide, diluted with phosphate buffer to appropriate concentrations ranging from 2 to 50 µM, and then incubated under the similar conditions but with neither GSH nor the NADPH-generating system incorporated. A control incubation with the same volume of dimethyl sulfoxide (less than 0.05% in the incubation mixture) as vehicle control was also performed in parallel.
Identification of Metabolites. The supernatants of incubations were directly subjected to HPLC-UV/MS analysis for the identification of metabolites. All the analytical conditions were identical to those reported previously (Lin et al., 2000a
, 2003
). Full-scan mass spectra were obtained over the mass range of m/z 150 to 850 in a negative ion mode for the identification of glutathione conjugates such as 7-GSH-DHR and clivoric acid or in a positive ion mode for the determination of DHR, deacetylclivorine, and the intact clivorine. A direct comparison of retention time, UV, and mass spectra of each metabolite with that of the authentic sample was also conducted for the confirmation of the identity of each metabolite found.
Furthermore, the novel metabolite deacetylclivorine was prepared from a scaled-up microsomal incubation (100 ml) in the absence of the NADPH-generating system. The obtained incubates were lyophilized, and the residues were extracted with 80% methanol (2 x 25 ml). The combined methanol extracts were centrifuged at 10,000g at 4°C for 20 min and then concentrated under reduced pressure to dryness. The residues were reconstituted into water, filtered, and subjected to preparative HPLC with a Hamilton (Reno, NV) preparative PRP-1 column (100 x 7 mm, 5 µm) coupled with a Hamilton PRP-1 guard column (50 x 4.1 mm, 5 µm). The mobile phase consisted of acetonitrile (A) and 0.01% formic acid (B) using the following gradient elution: initial 0 to 5 min, 100% B; 5 to 15 min, linear change to 60% B and then maintained for 15 min. The flow rate was kept constant at 1.0 ml/min. The eluted fractions containing deacetylclivorine were collected and concentrated under reduced pressure to remove acetonitrile and formic acid followed by lyophilization to yield colorless oil. The identity of the isolated deacetylclivorine was confirmed by MS analysis with a direct loop infusion, and the purity (
99%) was determined by HPLC-UV. All the spectroscopic and analytical conditions were the same as reported previously (Lin et al., 1998b
; Cui and Lin, 2000
). For the further structural elucidation, the MS/MS spectrum of deacetylclivorine was obtained under collision-induced dissociation. The collision energy was 50 V with argon at the collision gas setting 0.20 Pa (Lin et al., 1998b
).
Quantification of Metabolites. For the quantitative study of each metabolite in individual incubates, our previously developed HPLC-UV method was adopted by using a specific two-column setup with a Hamilton PRP-1 guard column (50 x 4.1 mm, 5 µm) and a Hamilton PRP-1 analytical column (150 x 4.1 mm, 5 µm) (Cui and Lin, 2000
). The incubated blank samples spiked with standards were also analyzed under the same condition, and a direct comparison of the retention time and UV spectrum of each analyte with that of the corresponding standard was conducted. Calibration curves for clivorine and its known metabolites were prepared as described previously (Cui and Lin, 2000
). Validations including the measurement of intraday and interday variations were conducted in the present study. In the case of the novel deacetylclivorine, the isolated pure deacetylclivorine (five concentrations over a range of 6.8108 µg/ml) and retrorsine as an internal standard were spiked into the blank microsomal incubation mixtures to construct a calibration curve. A linear calibration with the concentration of deacetylclivorine as a function of peak area ratio (analyte/internal standard) was obtained. Quantities of individual analytes present in different incubates were determined from the corresponding calibration curves constructed at the detection wavelength of 230 nm. Furthermore, DHR-derived bound pyrroles were determined by adopting a previously published method using a spectrophotometric analysis of the specific chromophore formed via reacting pyrrole functional group with Ehrlich reagent (Yan and Huxtable, 1995
; Lin et al., 2000a
, 2002
, 2003
).
|
| Results |
|---|
|
|
|---|
Further investigation confirmed that deacetylclivorine was formed after incubation of clivorine both in the presence and absence of the NADPH-generating system with female rat S9 and microsomes but not cytosolic fractions. On the other hand, incubations of clivorine with male rat liver S9, microsomes, and cytosolic fractions, as well as various controls and phosphate buffer solution, did not generate this novel metabolite. The results indicated that deacetylclivorine was a female rat-specific metabolite and could only be produced under the catalysis of the NADPH-independent microsomal enzymes. To the best of our knowledge, deacetylclivorine is a novel and female rat-specific metabolite characterized for the first time. Based on the results, the microsomal metabolic pathway of clivorine in female rat liver was delineated as shown in Fig. 1.
Quantification of Metabolites. All the known metabolites and the intact clivorine were quantified by adopting our previously developed HPLC-UV method (Cui and Lin, 2000
). The present validation studies resulted in good linearities (r2
0.98) for each of individual analytes with overall intraday and interday variations of less than 11%. For the novel metabolite, a calibration curve of deacetylclivorine was obtained with a good linearity (r2 = 0.9995). The results showed that deacetylclivorine was the predominant metabolite in all the female rat hepatic microsomal incubations. Furthermore, in the absence of the NADPH-generating system, amount of deacetylclivorine formed in a 1-h incubation significantly increased (54.87 ± 9.30 versus 19.44 ± 3.00 nmol/mg protein, p < 0.001) (Table 1) and was the only metabolite found in the NADPH-independent metabolism.
|
It is well established that the metabolic activation of clivorine is via oxidative N-demethylation to generate pyrrolic ester, which then undergoes adduct formation leading to hepatotoxicity (Mori et al., 1985
; Buhler et al., 1990
; Huxtable, 1990
; Lin et al., 2000a
, 2002
, 2003
; Fu et al., 2002
, 2004
). Because further metabolisms of pyrrolic ester, including adduct formations, all produce clivoric acid (Fig. 1), the rate of the metabolic activation can be estimated from the clivoric acid formation. In female rat liver microsome, about 30% of clivorine was metabolized within 60 min, and approximately 16% hydrolysis and 4% metabolic activation (Fig. 3, control incubation) were observed based on the measurement of amounts of deacetylclivorine and clivoric acid formed, respectively. The results showed that the hydrolysis to form deacetylclivorine was the predominant pathway in hepatic microsomal metabolism of clivorine in female rats.
|
On the other hand, deacetylation of clivorine to generate deacetylclivorine occurred in the absence of the NADPH-generating system and was not affected by any of the P450 isozyme inhibitors tested (Table 1), indicating that the formation of deacetylclivorine in female rats was independent of P450 monooxygenases. Furthermore, deacetylclivorine was generated only in female rat liver S9 and microsomal but not cytosolic incubations; thus, the responsible enzymes are most likely the microsomal carboxylesterases. Both nonselective (TOCP) and selective (PMSF toward hydrolase A) carboxylesterase inhibitors were found to significantly and dose-dependently inhibit the formation of deacetylclivorine (Table 2), and significantly higher inhibitory potency of PMSF was observed (i.e., IC50 6.34 ± 0.97 µM PMSF versus 16.43 ± 1.18 µM TOCP; p < 0.001). Furthermore, at a high concentration of 100 µM, PMSF totally abolished the hydrolysis pathway (data not shown). The results suggested that microsomal carboxylesterases, in particular hydrolase A isoform in female rats, played a key role in catalyzing direct hydrolysis of clivorine to form the novel and gender-selective metabolite deacetylclivorine.
|
| Discussion |
|---|
|
|
|---|
In the present study, it is interesting to note that the constitutive female rat-predominant P450 isozymes, including CYP2A1, CYP2C6, CYP2C7, CYP2C12, and CYP2E1, did not catalyze the metabolic activation of clivorine (Table 1), whereas similar to male rats, CYP3A1/2 isozymes were also observed to mediate the metabolic activation via an oxidative N-demethylation to form the toxic pyrrolic ester in female rats (Fig. 1). It is well documented that lower levels of CYP3A subfamily, especially CYP3A2, were found in female rats (Bandiera and Dworschak, 1992
; Pampori and Shapiro, 1999
; Agrawal and Shapiro, 2000
, 2003
). Therefore, it is not surprising to observe that of the 30% metabolism of clivorine in female rats in 1 h, the metabolic activation pathway only accounted for about 4%, which is significantly lower than the previous reported 21% in male rats (Lin et al., 2003
). The lesser extent of metabolic activation of clivorine in female rat liver microsomes is probably because of the lower activity of CYP3A1/2 isozymes. In addition, a new direct hydrolysis pathway, which accounted for about 16% of clivorine metabolism, was identified, showing that direct hydrolysis dominated hepatic microsomal metabolism of clivorine in female rats.
It is noted that two unknown putative metabolites were suggested in our previous report on the microsomal metabolism of clivorine in female rats (Lin et al., 2003
). The present study confirmed that only deacetylclivorine was the novel and female rat-specific metabolite. The second putative metabolite, determined not to be related to clivorine, was formed after incubation of female rat liver microsomes with the NADPH-generating system and decomposed within 4 h at room temperature (data not shown). The female rat-specific metabolite deacetylclivorine was unequivocally identified for the first time. Apparently, deacetylclivorine is speculated to be more hydrophilic than clivorine because the ester group in clivorine has been changed to a hydroxyl group in this metabolite.
The recoveries obtained for all the incubations were 90 to 100% (Fig. 3). In addition, possible metabolites of deacetylclivorine in all the incubated samples were further studied using both positive and negative ion mode of HPLC/MS/MS. Similar to the metabolic activation of clivorine, the possible metabolites generated via oxidative N-demethylation of deacetylclivorine to the corresponding pyrrolic ester (m/z 332 [M+H]+) and acid (m/z 203 [M-H]) were carefully examined, and no such metabolites were found. The results showed that apparently deacetylclivorine did not undergo further significant metabolism in female rat liver microsomes. Therefore, direct hydrolysis of clivorine to produce deacetylclivorine is considered to be not related to the metabolism-induced intoxication. Nevertheless, whether deacetylclivorine undergoes further metabolism in vivo and/or is directly excreted requires further investigations.
Further evaluation showed that deacetylclivorine could not be formed via chemical treatment of clivorine under either acidic or basic condition, indicating that this metabolite was generated enzymatically. Moreover, this female-specific metabolite was formed in microsomal but not cytosolic incubations, suggesting a microsomal carboxylesterase-mediated formation. Multiple forms of carboxylesterase are present in mammalian tissues, with the highest levels in the liver located in endoplasmic reticulum. Rat carboxylesterase consists of two isoforms: hydrolase A (ES-10) and hydrolase B (ES-4), and both isoforms hydrolyze xenobiotics containing an ester, thioester, or amide group (Lee et al., 1998
; Alexson et al., 2002
). Based on the nature of their responses to PMSF, hydrolase A and hydrolase B are also referred to as PMSF-sensitive and PMSF-insensitive hydrolase, respectively. Therefore, PMSF is commonly used as a selective hydrolase A inhibitor to distinguish the hydrolase A- or hydrolase B-mediated hydrolysis (Lee et al., 1998
; Alexson et al., 2002
). The results showed that both nonselective and selective hydrolase A inhibitors significantly and dose-dependently suppressed the hydrolysis of clivorine to form deacetylclivorine. Especially PMSF exhibited significantly higher inhibitory potency (Table 2) and totally abolished the hydrolysis pathway at a high concentration (100 µM). Therefore, hydrolase A was determined to be the key enzyme catalyzing the hydrolysis pathway. It is interesting to note that although there are no reports on gender differences in expression and activity of two rat carboxylesterase isoforms, the hydrolase A-mediated hydrolysis of clivorine could not be found in the incubations with male rat liver microsomes. The reason is unknown and is speculated to be caused by a balance among various competitive pathways. Further investigations are required.
It is interesting to note that extensive hydrolysis of clivorine by soluble hydrolases to form guinea pig-specific metabolite clivoric acid was suggested to be the main reason responsible for guinea pigs of both sexes to be resistance to clivorine intoxication. This hydrolysis pathway competed with the metabolic activation of clivorine and thus inhibited the generation of the toxic pyrrolic ester (Lin et al., 2002
). However, such a pathway could not be found in female rats' cytosolic incubations. On the other hand, catalyzed by microsomal hydrolase A, extensive hydrolysis of clivorine to form deacetylclivorine occurred in female rats. Similarly to guinea pigs, hydrolysis of clivorine to form deacetylclivorine in female rats was also found to compete with the metabolic activation. When the metabolic activation was blocked in the absence of the NADPH-generating system, the extent of hydrolysis significantly increased from 16% (control) to 40% (Fig. 3), suggesting that the overall effects might be caused by a balance among various metabolic pathways mediated by different enzymes. Thus, hydrolysis of clivorine to generate gender-selective deacetylclivorine could also be considered as a possible detoxification pathway, reducing the formation of toxic pyrrolic ester via competition with the metabolic activation in female rats.
Our previous study showed that male SD rats were significantly more susceptible (LD50, 91 ± 3 mg/kg, i.p.) than female rats (LD50, 114 ± 9 mg/kg, i.p., p < 0.05) to clivorine (Lin et al., 2003
). Additionally, predominance of metabolic activation and lacking of direct hydrolysis were observed in male rat liver microsomal metabolism of clivorine (Lin et al., 2000a
, 2003
). The present finding of the significantly lower metabolic activation (
4%) plus predominant direct hydrolysis (
16%) in female rats along with the fact of predominant bioactivation in male rats can explain the gender differences in susceptibility to clivorine-induced hepatotoxicity. Although the extent of in vivo metabolic activation of clivorine in rats is unknown, the gender difference in metabolism of clivorine observed in our in vitro studies may be extrapolated to the gender difference in vivo. However, further in vivo metabolic studies are warranted.
Together with the results of our present and previous studies, the main reasons for less susceptibility of female rats and guinea pigs of both sexes to clivorine intoxication are most likely the result of predominant detoxification hydrolysis and significantly less metabolic activation. Interestingly, the hydrolysis pathway was catalyzed by different enzymes, soluble hydrolases in guinea pigs as opposed to microsomal hydrolase A in female rats. The results suggest that the severity of PA intoxication depends on an overall balance between the metabolic activation and detoxification pathways, which vary with enzyme systems and species. On the other hand, any factor, such as enzyme induction and/or inhibition caused by diets, dietary supplements, nutraceuticals, and drug-drug and herb-drug interactions, may alter the metabolic balance in the body and thus has significant impact on PA intoxication to human health.
In conclusion, two pathways directly metabolizing clivorine were identified in female rat hepatic microsomal metabolism. The hydrolysis mediated by microsomal hydrolase A was the predominant pathway to generate novel and female rat-specific deacetylclivorine. The metabolic activation catalyzed by CYP3A1/2 to produce the toxic pyrrolic ester, followed by consequent adduct formation with macromolecules possibly leading to hepatotoxicity, was a minor route in female rats. This is most likely because of the significantly lower levels of the CYP3A subfamily, especially the CYP3A2 isoform, expressed in female rats. Therefore, we propose that the decreased susceptibility of female rats to clivorine intoxication may be caused by significantly lower rates of hepatic bioactivation, along with gender-specific hydrolysis to deacetylclivorine.
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
ABBREVIATIONS: PA, pyrrolizidine alkaloid(s); SD, Sprague-Dawley; P450, cytochrome P450; TOCP, triorthocresyl phosphate; PMSF, phenylmethylsulfonyl fluoride; GSH, glutathione; MS, mass spectrometry; HPLC, high-performance liquid chromatography; DHR, dehydroretronecine; 7-GSH-DHR, 7-glutathionyldehydroretronecine.
Address correspondence to: Ge Lin, Department of Pharmacology, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR. E-mail: linge{at}cuhk.edu.hk
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Yan, N. L. Ko, S.-L. Li, Y. K. Tam, and G. Lin Pharmacokinetics and Metabolism of Ligustilide, a Major Bioactive Component in Rhizoma Chuanxiong, in the Rat Drug Metab. Dispos., February 1, 2008; 36(2): 400 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tang, T. Akao, N. Nakamura, Z.-T. Wang, K. Takagawa, M. Sasahara, and M. Hattori In Vitro Metabolism of Isoline, a Pyrrolizidine Alkaloid from Ligularia duciformis, by Rodent Liver Microsomal Esterase and Enhanced Hepatotoxicity by Esterase Inhibitors Drug Metab. Dispos., October 1, 2007; 35(10): 1832 - 1839. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||